Journal of Ovarian Research

(The H4-Index of Journal of Ovarian Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis115
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review95
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective65
Ovarian cancer stem cells and targeted therapy62
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases54
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review53
miR-552 promotes ovarian cancer progression by regulating PTEN pathway48
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells47
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells46
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age45
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer45
Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review40
Withaferin A: a potential therapeutic agent against COVID-19 infection38
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis34
Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis34
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells32
Long non-coding RNAs in ovarian granulosa cells31
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer31
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized31
Therapeutic role of curcumin and its novel formulations in gynecological cancers30
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer28
Ovary does harbor stem cells - size of the cells matter!28
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer28
Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway28
LINC01094/miR-577 axis regulates the progression of ovarian cancer26
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells26
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols26
Adipocytes: active facilitators in epithelial ovarian cancer progression?26